Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Obeticholic acid by Intercept Pharmaceuticals for Biliary Atresia: Likelihood of Approval
Obeticholic acid is under clinical development by Intercept Pharmaceuticals and currently in Phase III for Biliary Atresia. According to GlobalData,...